Medical Condition News

RSS

Molecular mechanism that controls the transition from acute to chronic pain revealed

A new study led by University of California, Irvine researchers is the first to reveal the specific molecular mechanism that controls the transition from acute to chronic pain, and identifies this mechanism as a critical target for disease-modifying medicines.

25 Oct 2021

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

New research published in the medRxiv* preprint server suggests that COVID-19 illness incurs a greater 90-day risk of venous thrombosis than the flu. However, arterial thrombosis remains a higher risk among people with the influenza virus.

24 Oct 2021

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Researchers compare antibody titers elicited the Pfizer‐BioNTech mRNA and the classic inactivated virus Sinopharm vaccines.

24 Oct 2021

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.

24 Oct 2021

Health care costs for people with rare diseases have been underestimated, study shows

A new, retrospective study of medical and insurance records indicates health care costs for people with a rare disease have been underestimated and are three to five times greater than the costs for people without a rare disease.

22 Oct 2021

New project to deploy AI technology for detecting sight-threatening diabetic eye disease

St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust are leading a half a million pound project on artificial intelligence (AI), funded by NHSX and the Health Foundation, and enabled by the National Institute for Health Research.

22 Oct 2021

Nuclear Stammering Network offers support for adults who stammer

As active members (and in Michael and Paul's case, founder members) of the Nuclear Stammering Network, there are probably no better people to help us understand the impact of stammering than Michael Wright, Paul Martin and David Adams.

22 Oct 2021

Specific amino acid supplementation could prevent the development of dementia

Dementia- a condition involving the extreme loss of cognitive function- is caused by a variety of disorders, including Alzheimer's disease.

22 Oct 2021

Gene therapy strategy against Angelman syndrome shows early promise

Scientists at the UNC School of Medicine have reported in the journal JCI Insight encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.

22 Oct 2021

Study reveals key role of fat cells in cognitive decline and neurodegeneration

Findings published this week reveal new insights into the role of fat cells in cognitive decline and neurodegeneration, according to a study that involves the oxidant amplification loop led by Marshall University scientists.

22 Oct 2021

Antidepressant offers no improvement in agitation for people with dementia, study shows

A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even increase mortality, according to a new study.

22 Oct 2021

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Interleukin-12 - a messenger molecule of immune cells - was long considered to trigger the development of psoriasis.

22 Oct 2021

Researchers identify a potential pathogenic link between IBD and mental comorbidities

In response to gut inflammation, such as that caused by inflammatory bowel disease (IBD), the vascular barrier in the brain choroid plexus closes, locking down access to the brain, according to a new study.

22 Oct 2021

Researchers find a new way to analyze diseased and healthy cells from brain tumor patients

Scientists studying the most common and aggressive type of brain tumor in adults have discovered a new way of analyzing diseased and healthy cells from the same patient.

22 Oct 2021

Targeted drug shows promising activity in kidney cancer patients with brain metastases

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.

21 Oct 2021

Medical Condition News

Molecular mechanism that controls the transition from acute to chronic pain revealed

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

A comparison between Pfizer/BioNTech's and Sinopharm's SARS-CoV-2 vaccines

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Health care costs for people with rare diseases have been underestimated, study shows

New project to deploy AI technology for detecting sight-threatening diabetic eye disease

Nuclear Stammering Network offers support for adults who stammer

Specific amino acid supplementation could prevent the development of dementia

Gene therapy strategy against Angelman syndrome shows early promise

Study reveals key role of fat cells in cognitive decline and neurodegeneration

Antidepressant offers no improvement in agitation for people with dementia, study shows

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Researchers identify a potential pathogenic link between IBD and mental comorbidities

Researchers find a new way to analyze diseased and healthy cells from brain tumor patients

Targeted drug shows promising activity in kidney cancer patients with brain metastases

Mental health problems are common among smokers and adults with substance use disorders, study finds

New smartphone app provides point-of-care treatment algorithms for major depression

New mobile app facilitates continuous monitoring of the quality of life of cancer patients

Antisocial and prosocial behavior during COVID-19

Influence of age on innate and adaptive immunity in COVID-19 patients

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News